# In Vivo Human Study on Commercial Cellobiose as a Potential Prebiotic Candidate

> **NCT07097389** · NA · COMPLETED · sponsor: **Manxi Huang** · enrollment: 37 (actual)

## Conditions studied

- Gut -Microbiota
- As a Preliminary Study, Healthy Population's Gut Microbiota is Studied to See if Cellobiose Supplementation is Altering the Microbial Community or Not

## Interventions

- **DIETARY_SUPPLEMENT:** Cellobiose
- **DIETARY_SUPPLEMENT:** Oligofructose P95
- **DIETARY_SUPPLEMENT:** Maltodextrin (Placebo)

## Key facts

- **NCT ID:** NCT07097389
- **Lead sponsor:** Manxi Huang
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-31
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-06-01
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07097389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07097389, "In Vivo Human Study on Commercial Cellobiose as a Potential Prebiotic Candidate". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07097389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*